
BGG announces expansion of astaxanthin facility and research
The expanded flagship facility is expected to increase efficiency and innovation as well as reduce the carbon footprint.
In a May 16, 2025,
An inauguration day for the investment in the facility will be June 20.
“We are proud to unveil our latest investment in our state-of-the-art microalgae platform, spanning the entire value chain,” stated Chunhua Li, founder and principal shareholder of BGG, in the press release. “The enhanced synergy between manufacture and R&D will sharpen our innovation pipeline and accelerate speed to market.”
Previous expansions in 2023 and 2024 had doubled BGG’s production capacity.
“We are committed to staying ahead of global shifts to ensure uninterrupted service to our customers,” added Jürgen Nelis, BGG World CEO. “By strengthening our supply chain on multiple fronts, we are building a future-ready business that can thrive no matter how the trade landscape evolves.”
In addition to AstaZine, other product from BGG include ApplePhenon (apple polyphenols), CyaniMax (cyanidin 3 glucoside), FucoMa (fucoidan), LingonMax (lingonberry extract), and more.
BGG will be present at Stand 4D236 at Vitafoods Europe, taking place May 20-22 in Barcelona, Spain, and will be available to discuss the facility expansion, the company’s portfolio, and tariffs.
Reference
- BGG. AstaZine® Astaxanthin
https://bggworld.com/astaxanthin-astazinetm/ (accessed 2025-05-16).
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





